Project Health: Enhancing Effectiveness of a Dissonance-Based Obesity Prevention Program (PH)

August 7, 2024 updated by: Oregon Research Institute

Enhancing Effectiveness of a Dissonance-Based Obesity Prevention Program

This project seeks to improve the effectiveness of a novel dissonance-based obesity prevention program that has reduced future BMI gain and overweight/obesity onset by (a) experimentally testing whether implementing it in single- versus mixed-sex groups, which should increase dissonance-induction that contributes to weight gain prevention effects, and (b) experimentally testing whether adding food response and attention training, which theoretically reduces valuation of and attention for high-calorie foods, increases weight gain prevention effects. This randomized trial would be the first to experimentally manipulate these two factors in an effort to produce superior weight gain prevention effects. A brief effective obesity prevention program that can be easily, inexpensively, and broadly implemented to late adolescents at risk for excess weight gain, as has been the case with another dissonance-based prevention program, could markedly reduce the prevalence of obesity and associated morbidity and mortality.

Study Overview

Status

Active, not recruiting

Detailed Description

Prevention is key for combating obesity, but few programs have prevented future increases in BMI and onset of overweight/obesity, particularly during late adolescence when youth often assume responsibility for dietary intake and exercise choices. One exception is a brief 6-hr dissonance-based program (Project Health) wherein participants make small lasting incremental lifestyle changes to dietary intake and exercise to reach energy balance, and discuss costs of obesity, an unhealthy diet, and sedentary behavior, and benefits of leanness, a healthy diet, and exercise, which prompts them to align their attitudes with their publicly displayed behavior. These activities promote the internalization of health goals and executive control over lifestyle behaviors. Late adolescents randomized to Project Health showed fewer increases in BMI and a 41% and 43% reduction in overweight/obesity onset over 2-yr follow-up compared to a version of the program lacking dissonance induction activities and an obesity education condition. Project Health appears to be the first program to produce these key obesity prevention effects relative to an alternative intervention, but it is critical to increase effects. A dissonance-based prevention program was more effective when implemented in single- versus mixed-sex groups, theoretically, because it promoted greater participation in dissonance-inducing discussions. Aim 1a is to test whether the weight gain prevention effects will be larger when Project Health is implemented in single-sex groups; the investigators will randomize 450 17-20-year-olds to complete Project Health in female, male, or mixed-sex groups, assessing outcomes at pretest, post-test, and 6, 12, 24, and 36-month follow-ups. Aim 1b is to test whether greater participation in dissonance-inducing discussions and group cohesion mediate the effect of condition on any superior weight gain prevention effects. Adolescents who show greater functional Magnetic Resonance Imaging( fMRI)-assessed reward and attention region responsivity to food images exhibit elevated future weight gain, implying that reducing this responsivity may reduce future weight gain. In a pilot trial, late adolescents who completed go/no-go, stop-signal, and respond-signal computer training in which they repeatedly inhibit responses to high-calorie foods and respond to low-calorie foods, and dot-probe and visual-search computer tasks that train attention away from high-calorie foods and to low-calorie foods, showed a greater reduction in reward and attention region responsivity to, palatability rating of, and willingness to pay for, high-calorie foods, suggesting reduced valuation and attentional bias, as well as greater fat loss over 1-yr follow-up versus controls who completed the training with non-food images. Aim 2a is to test whether adding food response and attention training to Project Health will produce larger weight gain prevention effects. Participants in the 3 conditions will be randomized to complete response and attention training for 25-mins after each of the 6-sessions with either food or non-food images. Aim 2b is to test whether reduced palatability ratings of, willingness to pay, and attentional bias for high-calorie foods mediate the effect of training condition on any superior weight gain prevention effects.

During the Coronavirus Disease 2019 (COVID-19) shelter-at-home order, the investigators will not measure in-person only outcomes including assessments using the BodPod (a body composition tracking system using air displacement plethysmography), and height and weight measurement for BMI calculation for all participants that have assessments due during this order. The investigators will continue to conduct intervention groups that will be administered on a virtual platform.

Study Type

Interventional

Enrollment (Actual)

406

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Oregon
      • Eugene, Oregon, United States, 97403
        • Oregon Research Institute
    • Pennsylvania
      • Philadelphia, Pennsylvania, United States, 19104
        • Drexel University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

17 years to 20 years (Child, Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Current at least moderate weight concerns (response of moderate, severe or extreme to the presence of weight concerns question)
  • BMI between 20 and 30

Exclusion Criteria:

  • Current diagnosis of anorexia nervosa, bulimia nervosa, or binge eating disorder

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Factorial Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Mixed Group, Food Response Training
Participants in this arm will be assigned to receive Project Health in mixed-sex groups and will complete the food-focused response and attention training intervention.
A brief dissonance-based obesity prevention program delivered in six one-hour weekly sessions.
Individualized, computerized response and attention training consisting of five separate tasks designed to increase inhibitory control to reduce overeating.
Experimental: Mixed Group, Generic Response Training
Participants in this arm will be assigned to receive Project Health in mixed-sex groups and will complete the generic response and attention training intervention.
A brief dissonance-based obesity prevention program delivered in six one-hour weekly sessions.
Individualized, computerized response and attention training consisting of five separate tasks designed to increase inhibitory control to reduce overeating.
Experimental: Female Group, Food Response Training
Participants in this arm will be assigned to receive Project Health in female-only groups and will complete the food-focused response and attention training intervention.
A brief dissonance-based obesity prevention program delivered in six one-hour weekly sessions.
Individualized, computerized response and attention training consisting of five separate tasks designed to increase inhibitory control to reduce overeating.
Experimental: Female Group, Generic Response Training
Participants in this arm will be assigned to receive Project Health in female-only groups and will complete the generic response and attention training intervention.
A brief dissonance-based obesity prevention program delivered in six one-hour weekly sessions.
Individualized, computerized response and attention training consisting of five separate tasks designed to increase inhibitory control to reduce overeating.
Experimental: Male Group, Food Response Training
Participants in this arm will be assigned to receive Project Health in male-only groups and will complete the food-focused response and attention training intervention.
A brief dissonance-based obesity prevention program delivered in six one-hour weekly sessions.
Individualized, computerized response and attention training consisting of five separate tasks designed to increase inhibitory control to reduce overeating.
Experimental: Male Group, Generic Response Training
Participants in this arm will be assigned to receive Project Health in male-only groups and will complete the generic response and attention training intervention.
A brief dissonance-based obesity prevention program delivered in six one-hour weekly sessions.
Individualized, computerized response and attention training consisting of five separate tasks designed to increase inhibitory control to reduce overeating.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Body Fat
Time Frame: Baseline, 2 months, 8 months, 14 months, 26 months, and 38 months
Change in percentage of body fat (Not collected during COVID-19 shelter-at-home order)
Baseline, 2 months, 8 months, 14 months, 26 months, and 38 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Weight Concerns Scale from the Eating Disorder Examination Questionnaire (EDE-Q)
Time Frame: Baseline, 2 months, 8 months, 14 months, 26 months, and 38 months
Change in weight concerns. Scale scores range from 0 to 42 with higher scores being indicative of higher weight concerns.
Baseline, 2 months, 8 months, 14 months, 26 months, and 38 months
Beck Depression Index (BDI)
Time Frame: Baseline, 2 months, 8 months, 14 months, 26 months, and 38 months
Change in depressive symptoms
Baseline, 2 months, 8 months, 14 months, 26 months, and 38 months
Eating Disorder Interview (EDDI)
Time Frame: Baseline, 2 months, 8 months, 14 months, 26 months, and 38 months
Change in eating disorder symptoms
Baseline, 2 months, 8 months, 14 months, 26 months, and 38 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Eric M Stice, Ph.D., Oregon Research Institute

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 8, 2018

Primary Completion (Estimated)

March 31, 2025

Study Completion (Estimated)

June 30, 2025

Study Registration Dates

First Submitted

October 8, 2018

First Submitted That Met QC Criteria

October 16, 2018

First Posted (Actual)

October 18, 2018

Study Record Updates

Last Update Posted (Actual)

August 9, 2024

Last Update Submitted That Met QC Criteria

August 7, 2024

Last Verified

August 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • HD093598-01A1

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

The investigators will share all study data via the NICHD Data and Specimen Hub (DASH), which is the centralized resource for researchers to store and access data from NICHD-funded research studies to use for secondary research. All data, with the exception of video recordings of the participants in treatment (which cannot be effectively de-identified), will be provided.

IPD Sharing Time Frame

After all follow-up assessments are completed and the main project papers are published, a dataset stripped of identifiers prior to release will be made available without cost to researchers and analysts.

IPD Sharing Access Criteria

Individuals wishing to view Individual Participant Data (IPD) can create a free user account at DASH and submit a request which will be reviewed and approved through the NICHD Dash administrator.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Overweight and Obesity

Clinical Trials on Project Health

Subscribe